KY HB156

Amends KRS 158.832 and 158.836 to add intranasal epinephrine as an approved delivery method alongside injectable epinephrine for treating anaphylaxis in Kentucky schools

Students with documented life-threatening allergies may possess and use intranasal epinephrine devices at school, on school buses, during field trips, and at school-sponsored activities

Schools are encouraged to keep injectable or intranasal epinephrine devices in at least two locations (such as the school office and cafeteria) for emergency use on any student experiencing anaphylaxis

Kentucky Department for Public Health must develop clinical protocols addressing both injectable and intranasal epinephrine devices in the Core Clinical Service Guide manual

School employees authorized to administer medication are protected from civil liability for ordinary negligence when administering epinephrine to students believed to be having life-threatening allergic reactions